Phase I trial of SAR103168, a novel multi-kinase inhibitor, in patients with refractory/relapsed acute leukemia or high-risk myelodysplastic syndrome
Roboz, Gail J., Khoury, H. Jean, Jabbour, Elias, Session, Wilena, Ritchie, Ellen K., Miao, Harry, Faderl, Stefan, Zheng, Wei, Feldman, Eric J., Arellano, Martha, Morrison, J. Gilmour, Ravandi, Farhad
Published in Leukemia & Lymphoma (01.02.2015)
Published in Leukemia & Lymphoma (01.02.2015)
Get full text
Report
Phase I dose escalation study of lestaurtinib in patients with myelofibrosis
Hexner, Elizabeth O., Mascarenhas, John, Prchal, Josef, Roboz, Gail J., Baer, Maria R., Ritchie, Ellen K., Leibowitz, David, Demakos, Erin P., Miller, Crystal, Siuty, James, Kleczko, Jill, Price, Leah, Jeschke, Grace, Weinberg, Rona, Basu, Titiksha, Pahl, Heike L., Orazi, Attilio, Najfeld, Vesna, Marchioli, Roberto, Goldberg, Judith D., Silverman, Lewis R., Hoffman, Ronald
Published in Leukemia & Lymphoma (02.09.2015)
Published in Leukemia & Lymphoma (02.09.2015)
Get full text
Report